Signal2026-07-20
ClinicalTrials.gov

[PHASE2] A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Part of

Emerging Clinical Immunotherapy And Treatment Trials

Open primary sourceSee the whole picture